BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
530
[키워드] age
Analysis
association
BCG
BCG vaccination
BCG vaccination policy
biological basis
clinical evaluation
clinical trial
comparison
confounding factor
confounding factors
coronavirus disease
correlation
country
COVID-19
COVID-19 coronavirus
COVID-19 epidemic
COVID-19 mortality
COVID-19 pandemic
criteria
cross-protection
death
diagnostic test
Diseases
Effect
Effectiveness
epidemiological
Epidemiological study
European country
Evidence
Health
highlight
implication
increase in
limit
mitigate
Mortality
National
null hypothesis
pandemic
Prevalence
PROTECT
protective effect
Public
reduce
reduced
reduction in
required
Result
severe coronavirus disease
severe COVID-19
severity of COVID-19
signal
Significance
spread of COVID-19
suggested
Tuberculosis
vaccination
Vaccine
[DOI] 10.1073/pnas.2008410117 PMC 바로가기 [Article Type] 530
[DOI] 10.1073/pnas.2008410117 PMC 바로가기 [Article Type] 530